All News

The 2 companies are joining the women’s heart health initiative to promote awareness for cardiovascular disease prevention.

Mylan's drug is approved for 100 mcg/50 mcg, 250 mcg/50 mcg, and 500 mcg/50 mcg doses.

An FDA-approved genetically modified herpes virus can effectively treat metastatic melanoma when injected into the tumor.

Top news of the day across the health care landscape.

Top news of the day across the health care landscape.

As pharmacists, we manage and supervise people on a daily basis. It is important to distinguish what type of leader you are and which styles are more effective when dealing with different people in the pharmacy.

A targeted therapeutic approach shrank tumors caused by medulloblastoma, a deadly form a pediatric brain cancer.

Screening for and treatment of gonorrhea in pregnant women are also important strategies for preventing gonococcal ophthalmia neonatorum in babies, according to the Task Force.

The generic drug (Wixela Inhub, Mylan) is indicated to treat patients with asthma and chronic obstructive pulmonary disease, including bronchitis and emphysema.

The affected lots have been found to contain levels of ibuprofen concentration that are higher than the specified limit.

Individuals who perceive themselves to be at a high risk of HIV are more likely to accept pre-exposure prophylaxis (PrEP) than their peers.

The FDA has approved sumatriptan nasal spray (Tosymra, Promius Pharma) for the acute treatment of migraine with or without aura in adults.

Senate Finance Committee Chairman Senator Charles Grassley pledged to “get to the bottom of the insulin price problem.”

Senate Finance Committee Chairman Senator Charles Grassley pledged to “get to the bottom of the insulin price problem.”

In a congressional hearing held on Capitol Hill today, the damaging impact of rising insulin prices was the centerpiece of a larger discussion on rising drug costs in the United States.

Top news of the day across the health care landscape.

Analysis shows prices among all insulin types and products increased steadily between 2012 and 2016.

Top news of the day across the health care landscape.

Two recent studies analyzed factors that impacted response to therapy in patients with multiple myeloma.

A prescription drug ad broadcast during the musical on television has set the stage for a larger conversation about patient access to preexposure prophylaxis medication.

Syphilis is a sexually transmitted infection that has increased significantly among pregnant women and newborns.

The FDA has approved the use of ibrutinib (Imbruvica®, AbbVie) in combination with obinutuzumab (Gazyva®) for adult patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Ibrutinub plus obinutuzumab is the first FDA-approved non-chemotherapy combination regimen for chronic lymphocytic lymphoma and small lymphocytic lymphoma.

Better strategies are needed to adequately identify and prevent opportunistic infections and related deaths in patients with advanced HIV.

Top news of the day across the health care landscape.

Can you solve the pharmaceutical mystery?

Top news of the day across the health care landscape.

Health Mart has named Nimesh Jhaveri, MBA, RPh, its new president.

Post-cure care for hepatitis C can reduce the risk of liver disease progression in those with advanced fibrosis and ongoing risk factors for liver injury.

Conducted by the FDA, an analysis follows a series of recalls for some generic versions of the angiotensin II receptor blocker (ARB) medicines containing nitrosamine impurities that do not meet the agency’s safety standards.